Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 65 (5) , 403-409
- https://doi.org/10.1016/j.humimm.2004.02.007
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Mutations Conferring Ganciclovir Resistance in a Cohort of Patients with Acquired Immunodeficiency Syndrome and Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 2001
- Decrease of Cytomegalovirus Replication in Human Immunodeficiency Virus Infected–Patients after Treatment with Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapyAIDS, 1999
- Clinical Failure of CMV Retinitis With Intravitreal Cidofovir Is Associated With Antiviral ResistanceArchives of Ophthalmology (1950), 1998
- Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patientsAIDS, 1998
- Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patientsJournal of Medical Virology, 1995
- Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.Journal of Clinical Investigation, 1995
- Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assayAntiviral Research, 1992
- Foscarnet Therapy for Ganciclovir-Resistant Cytomegalovirus Retinitis in Patients with AIDSThe Journal of Infectious Diseases, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989